5don MSN
Rallybio shares successful early-stage results for rare disease drug; new trial set for late 2026
Rallybio Corporation RLYB on Tuesday shared results from its Phase 1 confirmatory pharmacokinetic/pharmacodynamic (PK/PD) ...
From football players to military personnel, people who suffer repeated head injuries often face serious long-term health issues. These include problems with memory, mood, and movement, and in some ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results